Ticker Details
Enliven Therapeutics, Inc.
IPO Date:	February 24, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.38B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.76 | 3.42%
Avg Daily Range (30 D):	$1.09 | 1.98%
Avg Daily Range (90 D):	$1.26 | 2.78%

Institutional Daily Volume
Avg Daily Volume:	.39M
Avg Daily Volume (30 D):	.8M
Avg Daily Volume (90 D):	1.02M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	1,499
Avg Institutional Trade:	$2M
Avg Institutional Trade (30 D):	$3.05M
Avg Institutional Trade (90 D):	$3.05M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.44M
Avg Closing Trade (30 D):	$3.79M
Avg Closing Trade (90 D):	$6.21M
Avg Closing Volume:	81.65K

News

Jun 27, 2026 @ 4:03 PM What to Know About OrbiMed's $39 Million Enliven T... Source: Jonathan Ponciano

Jun 24, 2026 @ 7:12 PM Medical Hedge Fund Sells 281,000 Shares of Enliven... Source: Brendan Coffey

Jun 1, 2026 @ 9:25 PM Enliven Therapeutics' Chief Medical Officer Sold 5... Source: Robert Izquierdo

Aug 13, 2025 @ 10:15 PM Enliven Posts Loss Beat and Cash Surge Source: Jesterai

Oct 14, 2024 @ 7:05 PM Enliven Therapeutics, Inc. Is a Great Choice for '... Source: Zacks

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.49	$-.38	$-.48
Diluted EPS	$-.49	$-.38	$-.48
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-32.49M	$-23.63M	$-29.67M
Operating Income / Loss	$-37.21M	$-27.82M	$-34.29M
Cost of Revenue
Net Cash Flow	$3.32M	$33.29M	$-2.84M
PE Ratio